Investigating the Molecular Roots of Lung Disease
Chief Scott Budinger, MD, and the other scientists in Pulmonary and Critical Care Medicine tackle some of the most common — and fatal — medical conditions in the world.
Browsing: "Pulmonology"
Testing New Therapies for Emphysema
Coils implanted into the lungs may improve exercise tolerance for patients with severe emphysema, according to a study that involved Northwestern Medicine investigators.
Uncovering How Cells Sense Oxygen Levels
Northwestern Medicine scientists have revealed that mitochondria detect changes in oxygen and activate a chain of events to respond to inadequate supply.
Investigating the Role of Pulmonary Veins in Asthma
MD/PhD student Sai Folmsbee aims to understand the role of the protein αT-catenin, found in heart cells, in the development of asthma.
New Roles for Mitochondria Uncovered
A new Northwestern Medicine study led by Navdeep Chandel, PhD, challenges the common understanding that energy production is mitochondria’s most important function.
New Player in Lung Cancer Progression Discovered
Northwestern Medicine scientists have shown for the first time that the Myosin 9b gene is correlated with lung cancer tumor formation and metastasis.
Estimating the Burden of Pneumonia Hospitalizations
Respiratory viruses were detected more frequently than bacteria in community-acquired pneumonia in adults, and incidence of pneumonia increased with age, according to new research.
Exploring How Heart and Lung Diseases Evolve As We Age
By examining how loss of lung function between young adulthood and middle age associated with changes in the heart, Northwestern Medicine scientists identified two heart-lung phenotypes that may form the basis for diseases that develop later in life.
Soy Supplements Do Not Improve Asthma
Despite previous findings suggesting a link between soy intake and decreased asthma severity, a new Northwestern Medicine study shows that soy supplements do not improve lung function for patients with asthma.
Groundbreaking Findings for Patients with Cystic Fibrosis
Treatment with two medications that target the most common genetic cause of cystic fibrosis improves lung function and lowers the rate of pulmonary exacerbations, according to results from a Northwestern Medicine clinical trial.